Level Four Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Level Four Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$437K	Hold	120,000	–	–	0.19%	137
2021 Q2	$523K	Hold	120,000	–	–	0.22%	121
2021 Q1	$493K	Hold	120,000	–	–	0.23%	120
2020 Q4	$479K	Buy	+120,000	New	+$388K	0.21%	139

Other funds holding ATRS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Level Four Financial's ATRS Position: Q3 2021 in Review

Level Four Financial held its Antares Pharma, Inc. (ATRS) position steady in Q3 2021 at 120,000 shares worth $437K. The position accounts for 0.19% of the portfolio, ranked #137.

Level Four Financial first reported a position in ATRS in Q4 2020 and has held it in 4 quarters since. The position peaked at $523K in Q2 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

Level Four Financial held 120,000 shares of Antares Pharma, Inc. worth $437K as of Q3 2021.
Level Four Financial left its Antares Pharma, Inc. share count unchanged in Q3 2021.
Antares Pharma, Inc. made up 0.19% of Level Four Financial's portfolio in Q3 2021, its #137 holding.
Level Four Financial first reported a position in Antares Pharma, Inc. in Q4 2020 and has held it in 4 quarters since.
Level Four Financial's Antares Pharma, Inc. position peaked at $523K in Q2 2021.
170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.